Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.880
-0.030 (-1.57%)
At close: Apr 27, 2026, 4:00 PM EDT
1.920
+0.040 (2.13%)
After-hours: Apr 27, 2026, 6:49 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $72.84 million as of April 27, 2026. Its market cap has increased by 44.31% in one year.
Market Cap
72.84M
Enterprise Value
-43.03M
1-Year Change
44.31%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $72.84M, a decrease of -69.02%. That is a compound annual growth rate of -28.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 74.00M | -2.69% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 77.38M |
| MAIA Biotechnology | 77.05M |
| aTyr Pharma | 76.98M |
| PMV Pharmaceuticals | 76.79M |
| Pliant Therapeutics | 76.77M |
| XBiotech | 76.52M |
| TScan Therapeutics | 75.73M |
| ImmuCell | 75.59M |